← Back to Search

Balance Training for Multiple Sclerosis

N/A

Waitlist Available

Research Sponsored by Wayne State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Stable medication regime for 3 months prior to enrollment

Able to follow study-related commands

Timeline

Screening 3 weeks

Treatment Varies

Follow Up outcome will be assessed at baseline visit and post-test visit (1 week later)

Awards & highlights

Study Summary

This trial is designed to study how well people with MS can learn new motor skills, and what factors might help predict successful learning.

Who is the study for?

This trial is for individuals aged 18-65 with Relapsing-Remitting Multiple Sclerosis who can walk with or without help. They must have been on a stable medication regime for the past 3 months and be able to follow study instructions. People are excluded if they have other neurological conditions, recent steroid use, metal implants incompatible with MRI, current pregnancy, or significant depression.Check my eligibility

What is being tested?

The study investigates how people with MS relearn motor skills through balance training. It aims to identify clinical and brain-related factors that predict successful learning of these skills. Participants will undergo cognitive tests, neuroimaging, and train on a balance task over four days followed by post-testing after two days.See study design

What are the potential side effects?

Since this trial focuses on balance training rather than drug intervention, typical side effects associated with medications are not expected. However, participants may experience fatigue or physical discomfort from the exercises involved in the motor skill learning process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My medications have not changed in the last 3 months.

Select...

I can understand and follow study instructions.

Select...

I can walk with or without help.

Select...

I am between 18 and 65 years old.

Select...

I have been diagnosed with Relapsing-Remitting MS.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ outcome will be assessed at baseline visit and post-test visit (1 week later)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~outcome will be assessed at baseline visit and post-test visit (1 week later)

This trial's timeline: 3 weeks for screening, Varies for treatment, and outcome will be assessed at baseline visit and post-test visit (1 week later) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Dual-Task Cost

Secondary outcome measures

Berg Balance Scale

Objective Balance Control

Trial Design

1Treatment groups

Experimental Treatment

Group I: ExperimentalExperimental Treatment1 Intervention

Balance Training

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Balance Training

2018

N/A

~960

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

Wayne State UniversityLead Sponsor

307 Previous Clinical Trials

108,314 Total Patients Enrolled

7 Trials studying Multiple Sclerosis

629 Patients Enrolled for Multiple Sclerosis

Media Library

Balance Training Clinical Trial Eligibility Overview. Trial Name: NCT03404388 — N/A

Multiple Sclerosis Research Study Groups: Experimental

Multiple Sclerosis Clinical Trial 2023: Balance Training Highlights & Side Effects. Trial Name: NCT03404388 — N/A

Balance Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03404388 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining positions available in this experiment for participants?

"Evidently, the clinicaltrial.gov database reflects that this medical trial is no longer accepting new participants; the study was initially posted on April 1st 2020 and most recently edited on April 25th 2022. Nevertheless, there are a plethora of other trials currently recruiting patients presently."

Answered by AI

Are individuals over 70 years of age eligible to participate in the experiment?

"The study's criteria necessitate that all participants are between 18 to 65 years old. There are 43 studies designed for minors and 391 protocols specifically tailored to individuals aged over 65."

Answered by AI

Is it feasible for me to join this experimental research?

"This clinical trial is seeking 150 people aged between 18 and 65 who have been diagnosed with multiple sclerosis. Eligible participants must display a Patient Determined Disease Steps (PDDS) score of less than 6.5, be able to understand instructions related to the study, and possess sufficient mobility - either independently or aided by an assistive device (Hohol, 1999; Learmonth, 2013)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Brain and Behavioral Influences on Motor Skill Learning in Multiple Sclerosis

Nora Fritz 2020. "Brain and Behavioral Influences on Motor Skill Learning in Multiple Sclerosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03404388.

All > Primary Progressive Multiple Sclerosis > Multiple Sclerosis